Are you a Health Professional? Jump over to the doctors only platform. Click Here

Inhaled hormone treatment offer breast cancer alternative

An inhaled hormone treatment may offer women at high risk of breast cancer an alternative to losing their breasts or […]

Phase III study of Herceptin for breast cancer.

The addition of a second chemotherapy drug to a regimen of breast cancer drug Herceptin and chemotherapy nearly doubles the […]

Virtual Cancer Centre has a new look!

Thanks to an astounding amount of feedback and comments, we are now proud to launch the new looking Virtual Cancer […]

Trial of MabThera in patients with Non Hodgkin’s Lymphoma

Investigational randomised data demonstrate potential of early and extended MabThera (rituximab) use to delay disease progression in patients...

Study strengthens link between smoking and Hodgkin’s disease

Latest research has shown that people who smoke are almost twice as likely to develop Hodgkin’s Disease, a type of […]

Protecting Hearing from Chemotherapy

Chemotherapy is meant to help a person live longer by killing the cancer, but it can also unfortunately decrease the […]

Pemetrexed – Novel Antifolate Clinically Active against Multiple Solid Tu…

The following is an abstract taken form a report authored by Axel R. Hanauske, Victor Chen, Paolo Paoletti and Clet […]

Shortage of Radiologists means 10,000 cancer patients go untreated

As previously reported, health experts are warning Australia is facing a serious shortage of radiologists. A new study by the […]

Risk of Melanoma and skin colour – no difference

Adelaide researchers say that by checking people’s buttocks, they have found there is no difference in the risk of skin […]

State of the Australian Health Industry

An interesting report by Martin Van Der Weyden discussed the state of the Australian health industry, in particular, research and […]

Study into DNA and skin cancer

Queensland researchers have begun a new study that could help identify people who are at risk of developing skin cancer. […]

Roles of cyclin D1 and cyclin E as response markers assessed

Sydney researchers have investigated the potential roles of cyclin D1 and cyclin E expression as markers of therapeutic responsiveness to […]

Swedish study hints mesothelioma incidence might drop faster than expected

Swedish scientists have reported that the incidence of asbestos-related pleural mesothelioma seems to have plateaued in Sweden, however it is...

Better testing with fine needle aspirates

Fine needle aspirates (FNAs) from breast cancer contain a higher percentage of malignant cells than do surgical biopsy specimens,...

Hot from COSA – patients not always receiving the best treatment

National audit of newly diagnosed patients shows some patients are not receiving optimal treatment for colorectal cancers. “The majority of...